Report Cover

Global Antibody Drug Conjugates Market Research Report 2021, Forecast to 2026


Antibody-drug Conjugates or ADCs are highly targeted biopharmaceutical drugs that combine monoclonal antibodies specific to surface antigens present on particular tumor cells with highly potent anti-cancer agents linked via a chemical linker.
The report forecast global Antibody Drug Conjugates market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Antibody Drug Conjugates industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
    Adcetris
    Kadcyla

Market Segment by Product Application
    Breast Cancer
    Lymphoma

Finally, the report provides detailed profile and data information analysis of leading company.
    F. Hoffman-La Roche
    Novartis AG
    Takeda Pharmaceutical
    Pfizer
    Seattle Genetics
    Genentech
    Immunogen
    Progenics Pharmaceuticals
    Bayer Healthcare Pharmaceuticals

Insights and Tools:
 Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
 Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
 The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
 Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
 The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
 In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
    1.To study and analyze the global Antibody Drug Conjugates consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
    2.To understand the structure of Antibody Drug Conjugates market by identifying its various subsegments.
    3.Focuses on the key global Antibody Drug Conjugates manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
    4.To analyze the Antibody Drug Conjugates with respect to individual growth trends, future prospects, and their contribution to the total market.
    5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    6.To project the consumption of Antibody Drug Conjugates submarkets, with respect to key regions (along with their respective key countries).
    7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents

Global Antibody Drug Conjugates Market Research Report 2021, Forecast to 2026

1 Market Study Overview
    1.1 Study Objectives
    1.2 Antibody Drug Conjugates Introduce
    1.3 Combined with the Analysis of Macroeconomic Indicators
    1.4 Brief Description of Research methods
    1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
    2.1 Antibody Drug Conjugates Segment by Type
        2.1.1 Adcetris
        2.1.2 Kadcyla
    2.2 Market Analysis by Application
        2.2.1 Breast Cancer
        2.2.2 Lymphoma
    2.3 Global Antibody Drug Conjugates Market Comparison by Regions (2016-2026)
        2.3.1 Global Antibody Drug Conjugates Market Size (2016-2026)
        2.3.2 North America Antibody Drug Conjugates Status and Prospect (2016-2026)
        2.3.3 Europe Antibody Drug Conjugates Status and Prospect (2016-2026)
        2.3.4 China Antibody Drug Conjugates Status and Prospect (2016-2026)
        2.3.5 Japan Antibody Drug Conjugates Status and Prospect (2016-2026)
        2.3.6 Southeast Asia Antibody Drug Conjugates Status and Prospect (2016-2026)
    2.4 Basic Product Information
        2.4.1 Basic Product Information & Technology Development History
        2.4.2 Product Manufacturing Process
        2.4.3 Interview with Major Market Participants
        2.4.4 High-end Market Analysis and Forecast
    2.5 Coronavirus Disease 2019 (Covid-19): Antibody Drug Conjugates Industry Impact
        2.5.1 Antibody Drug Conjugates Business Impact Assessment - Covid-19
        2.5.2 Market Trends and Antibody Drug Conjugates Potential Opportunities in the COVID-19 Landscape
        2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
    3.1 Global Antibody Drug Conjugates Sales and Market Share by Manufacturer (2016-2021)
    3.2 Global Antibody Drug Conjugates Revenue and Market Share by Manufacturer (2016-2021)
    3.3 Global Antibody Drug Conjugates Industry Concentration Ratio (CR5 and HHI)
    3.4 Top 5 Antibody Drug Conjugates Manufacturer Market Share
    3.5 Top 10 Antibody Drug Conjugates Manufacturer Market Share
    3.6 Date of Key Manufacturers Enter into Antibody Drug Conjugates Market
    3.7 Key Manufacturers Antibody Drug Conjugates Key Manufacturers
    3.8 Mergers & Acquisitions Planning

4 Analysis of Antibody Drug Conjugates Industry Key Manufacturers
    4.1 F. Hoffman-La Roche
        4.1.1 Compan Detail
        4.1.2  F. Hoffman-La Roche Antibody Drug Conjugates Product Introduction, Application and Specification
        4.1.3  F. Hoffman-La Roche 137 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
        4.1.4  Main Business Overview
        4.1.5  F. Hoffman-La Roche News
    4.2 Novartis AG
        4.2.1 Compan Detail
        4.2.2  Novartis AG Antibody Drug Conjugates Product Introduction, Application and Specification
        4.2.3  Novartis AG Antibody Drug Conjugates Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
        4.2.4  Main Business Overview
        4.2.5  F. Hoffman-La Roche News
    4.3 Takeda Pharmaceutical
        4.3.1 Compan Detail
        4.3.2  Takeda Pharmaceutical Antibody Drug Conjugates Product Introduction, Application and Specification
        4.3.3  Takeda Pharmaceutical Antibody Drug Conjugates Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
        4.3.4  Main Business Overview
        4.3.5  Takeda Pharmaceutical News
    4.4 Pfizer
        4.4.1 Compan Detail
        4.4.2  Pfizer Antibody Drug Conjugates Product Introduction, Application and Specification
        4.4.3  Pfizer Antibody Drug Conjugates Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
        4.4.4  Main Business Overview
        4.4.5  Pfizer News
    4.5 Seattle Genetics
        4.5.1 Compan Detail
        4.5.2  Pfizer Antibody Drug Conjugates Product Introduction, Application and Specification
        4.5.3  Seattle Genetics Antibody Drug Conjugates Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
        4.5.4  Main Business Overview
        4.5.5  Seattle Genetics News
    4.6 Genentech
        4.6.1 Compan Detail
        4.6.2  Genentech Antibody Drug Conjugates Product Introduction, Application and Specification
        4.6.3  Genentech Antibody Drug Conjugates Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
        4.6.4  Main Business Overview
        4.6.5  Genentech News
    4.7 Immunogen
        4.7.1 Compan Detail
        4.7.2  Immunogen Antibody Drug Conjugates Product Introduction, Application and Specification
        4.7.3  Immunogen Antibody Drug Conjugates Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
        4.7.4  Main Business Overview
        4.7.4  Main Business Overview
    4.8 Progenics Pharmaceuticals
        4.8.1 Compan Detail
        4.8.2  Progenics Pharmaceuticals Antibody Drug Conjugates Product Introduction, Application and Specification
        4.8.3  Progenics Pharmaceuticals Antibody Drug Conjugates Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
        4.8.4  Main Business Overview
        4.8.5  Progenics Pharmaceuticals News
    4.9 Bayer Healthcare Pharmaceuticals
        4.9.1 Compan Detail
        4.9.2  Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Product Introduction, Application and Specification
        4.9.3  Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
        4.9.4  Main Business Overview
        4.9.5  Bayer Healthcare Pharmaceuticals News

5  Global Antibody Drug Conjugates Market Segment by Big Type
    5.1 Global Antibody Drug Conjugates Revenue, Sales and Market Share by Big Type (2016-2021)
        5.1.1 Global Antibody Drug Conjugates Sales and Market Share by Big Type (2016-2021)
        5.1.2 Global Antibody Drug Conjugates Revenue and Market Share by Big Type (2016-2021)
    5.2 Adcetris Sales Growth Rate and Price
        5.2.1 Global Adcetris Sales Growth Rate (2016-2021)
        5.2.2 Global Adcetris Price (2016-2021)
    5.3 Kadcyla Sales Growth Rate and Price
        5.3.1 Global Kadcyla Sales Growth Rate (2016-2021)
        5.3.2 Global Kadcyla Price (2016-2021)

6 Global Antibody Drug Conjugates Market Segment by Big Application
    6.1 Global Antibody Drug Conjugates Sales Market Share by Big Application (2016-2021)
    6.2 Breast Cancer Sales Growth Rate (2016-2021)
    6.3 Lymphoma Sales Growth Rate (2016-2021)

7 Global Antibody Drug Conjugates Forecast
    7.1 Global Antibody Drug Conjugates Revenue, Sales and Growth Rate (2021-2026)
    7.2 Antibody Drug Conjugates Market Forecast by Regions (2021-2026)
        7.2.1 North America Antibody Drug Conjugates Market Forecast (2021-2026)
        7.2.2 Europe Antibody Drug Conjugates Market Forecast (2021-2026)
        7.2.3 China Antibody Drug Conjugates Market Forecast (2021-2026)
        7.2.4 Japan Antibody Drug Conjugates Market Forecast (2021-2026)
        7.2.5 Southeast Asia Antibody Drug Conjugates Market Forecast (2021-2026)
        7.2.6 Other Regions Antibody Drug Conjugates Market Forecast (2021-2026)
    7.3 Antibody Drug Conjugates Market Forecast by Type (2021-2026)
        7.3.1 Global Antibody Drug Conjugates Sales Forecast by Type (2021-2026)
        7.3.2 Global Antibody Drug Conjugates Market Share Forecast by Type (2021-2026)
    7.4 Antibody Drug Conjugates Market Forecast by Application (2021-2026)
        7.4.1 Global Antibody Drug Conjugates Sales Forecast by Application (2021-2026)
        7.4.2 Global Antibody Drug Conjugates Market Share Forecast by Application (2021-2026)

8 Market Analysis
        8.1.1 Market Overview
        8.1.2 Market Opportunities
        8.1.3 Market Risk
        8.1.4 Market Driving Force
        8.1.5 Porter's Five Forces Analysis
        8.1.6 SWOT Analysis

9 Antibody Drug Conjugates Related Market Analysis
    9.1 Upstream Analysis
        9.1.1 Macro Analysis of Upstream Markets
        9.1.2 Key Players in Upstream Markets
        9.1.3 Upstream Market Trend Analysis
        9.1.4 Antibody Drug Conjugates Manufacturing Cost Analysis
    9.2 Downstream Market Analysis
        9.2.1 Macro Analysis of Down Markets
        9.2.2 Key Players in Down Markets
        9.2.3 Downstream Market Trend Analysis
        9.2.4 Sales Channel, Distributors, Traders and Dealers

10 Research Findings and Conclusion

List of Tables and Figures Figure Product Picture Antibody Drug Conjugates Figure Market Concentration Ratio and Market Maturity Analysis of Antibody Drug Conjugates Figure Bottom-up and Top-down Approaches for This Report Figure Part of Our External Database Figure Part of Our External Database Figure Key Executives Interviewed Table Global Antibody Drug Conjugates Market Size by Big Type Figure Global Market Share of Antibody Drug Conjugates by Big Type in 2020 Figure Adcetris Picture (2016-2021) Global Antibody Drug Conjugates Market Size by Big Application Table Global Antibody Drug Conjugates Market Size by Application Figure Global Antibody Drug Conjugates Market Share by Big Application in 2020 Figure Breast Cancer Picture Figure Lymphoma Picture Table Global Antibody Drug Conjugates Comparison by Regions (M USD) (2016-2026) Figure Global Antibody Drug Conjugates Market Size (Million US$) (2016-2026) Figure North America Antibody Drug Conjugates Revenue (Million US$) Growth Rate (2016-2026) Figure Europe Antibody Drug Conjugates Revenue (Million US$) Growth Rate (2016-2026) Figure China Antibody Drug Conjugates Revenue (Million US$) Growth Rate (2016-2026) Figure Japan Antibody Drug Conjugates Revenue (Million US$) Growth Rate (2016-2026) Figure Southeast Asia Antibody Drug Conjugates Revenue (Million US$) Growth Rate (2016-2026) Table Business Impact Assessment - Covid-19 Table Market Trends and Antibody Drug Conjugates Potential Opportunities in the COVID-19 Landscape Table Measures / Proposal against Covid-19 Table Global Antibody Drug Conjugates Sales by Manufacturer (2016-2021) Figure Global Antibody Drug Conjugates Sales Market Share by Manufacturer in 2020 Table Global Antibody Drug Conjugates Revenue by Manufacturer (2016-2021) Figure Global Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2020 Table Global Antibody Drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Antibody Drug Conjugates Manufacturer (Revenue) Market Share in 2020 Figure Top 10 Antibody Drug Conjugates Manufacturer (Revenue) Market Share in 2020 Table Date of Key Manufacturers Enter into Antibody Drug Conjugates Market Table Key Manufacturers Antibody Drug Conjugates Product Type Table Mergers & Acquisitions Planning Table F. Hoffman-La Roche Company Profile Table Antibody Drug Conjugates Product Introduction, Application and Specification of F. Hoffman-La Roche Table Antibody Drug Conjugates Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021 Table Company One Main Business Table Company One Recent Development Table Novartis AG Company Profile Table Antibody Drug Conjugates Product Introduction, Application and Specification of Novartis AG Table Antibody Drug Conjugates Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Novartis AG Recent Development Table Takeda Pharmaceutical Company Profile Table Antibody Drug Conjugates Product Introduction, Application and Specification of Takeda Pharmaceutical Table Antibody Drug Conjugates Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Takeda Pharmaceutical Main Business Table Takeda Pharmaceutical Recent Development Table Pfizer Company Profile Table Antibody Drug Conjugates Product Introduction, Application and Specification of Pfizer Table Antibody Drug Conjugates Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Pfizer Main Business Table Pfizer Recent Development Table Pfizer Main Business Table Pfizer Recent Development Table Seattle Genetics Company Profile Table Antibody Drug Conjugates Product Introduction, Application and Specification of Seattle Genetics Table Antibody Drug Conjugates Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Seattle Genetics Main Business Table Seattle Genetics Recent Development Table Genentech Company Profile Table Antibody Drug Conjugates Product Introduction, Application and Specification of Genentech Table Antibody Drug Conjugates Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Genentech Main Business Table Genentech Recent Development Table Immunogen Company Profile Table Antibody Drug Conjugates Product Introduction, Application and Specification of Immunogen Table Antibody Drug Conjugates Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Immunogen Main Business Table Immunogen Recent Development Table Progenics Pharmaceuticals Company Profile Table Antibody Drug Conjugates Product Introduction, Application and Specification of Progenics Pharmaceuticals Table Antibody Drug Conjugates Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Progenics Pharmaceuticals Main Business Table Progenics Pharmaceuticals Recent Development Table Bayer Healthcare Pharmaceuticals Company Profile Table Antibody Drug Conjugates Product Introduction, Application and Specification of Bayer Healthcare Pharmaceuticals Table Antibody Drug Conjugates Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Bayer Healthcare Pharmaceuticals Main Business Table Bayer Healthcare Pharmaceuticals Recent Development Figure Global Antibody Drug Conjugates Sales and Growth Rate (2016-2021) Figure Global Antibody Drug Conjugates Revenue and Growth Rate (2016-2021) Table Global Antibody Drug Conjugates Sales by Regions (2016-2021) Figure Global Antibody Drug Conjugates Sales Market Share by Regions in 2020 Table Global Antibody Drug Conjugates Revenue by Regions (2016-2021) Figure Global Antibody Drug Conjugates Revenue Market Share by Regions in 2020 Figure North America Antibody Drug Conjugates Sales and Growth Rate (2016-2021) Figure Europe Antibody Drug Conjugates Sales and Growth Rate (2016-2021) Figure China Antibody Drug Conjugates Sales and Growth Rate (2016-2021) Figure Japan Antibody Drug Conjugates Sales and Growth Rate (2016-2021) Figure Southeast Asia Antibody Drug Conjugates Sales and Growth Rate (2016-2021) Figure Other Regions Antibody Drug Conjugates Sales and Growth Rate (2016-2021) Table Global Antibody Drug Conjugates Sales by Big Type (2016-2021) Table Global Antibody Drug Conjugates Sales Market Share by Big Type (2016-2021) Figure Global Antibody Drug Conjugates Sales Market Share by Big Type in 2019 Table Global Antibody Drug Conjugates Revenue by Big Type (2016-2021) Table Global Antibody Drug Conjugates Revenue Market Share by Big Type (2016-2021) Table Global Antibody Drug Conjugates Revenue Market Share by Big Type in 2019 Figure Global Adcetris Sales Growth Rate (2016-2021) Figure Global Adcetris Price (2016-2021) Figure Global Kadcyla Sales Growth Rate (2016-2021) Table Global Antibody Drug Conjugates Sales by Big Application (2016-2021) Table Global Antibody Drug Conjugates Sales Market Share by Big Application (2016-2021) Figure Global Antibody Drug Conjugates Sales Market Share by Big Application in 2019 Figure Global Breast Cancer Sales Growth Rate (2016-2021) Figure Global Lymphoma Sales Growth Rate (2016-2021) Figure Global Antibody Drug Conjugates Sales and Growth Rate (2021-2026) Figure Global Antibody Drug Conjugates Revenue and Growth Rate (2021-2026) Table Global Antibody Drug Conjugates Sales Forecast by Regions (2021-2026) Table Global Antibody Drug Conjugates Market Share Forecast by Regions (2021-2026) Figure North America Sales Antibody Drug Conjugates Market Forecast (2021-2026) Figure Europe Sales Antibody Drug Conjugates Market Forecast (2021-2026) Figure China Sales Antibody Drug Conjugates Market Forecast (2021-2026) Figure Japan Sales Antibody Drug Conjugates Market Forecast (2021-2026) Figure Southeast Asia Sales Antibody Drug Conjugates Market Forecast (2021-2026) Figure Other Regions Sales Antibody Drug Conjugates Market Forecast (2021-2026) Table Global Antibody Drug Conjugates Sales Forecast by Type (2021-2026) Table Global Antibody Drug Conjugates Market Share Forecast by Type (2021-2026) Table Global Antibody Drug Conjugates Sales Forecast by Application (2021-2026) Table Global Antibody Drug Conjugates Market Share Forecast by Application (2021-2026) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table Macro Analysis of Upstream Markets Table Key Players in Upstream Markets Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Antibody Drug Conjugates Table Macro Analysis of Down Markets Table Key Players in Down Markets Table Key Players of Downstream Markets Figure Sales Channel Figure North America Antibody Drug Conjugates Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Antibody Drug Conjugates Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Antibody Drug Conjugates Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Antibody Drug Conjugates Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Antibody Drug Conjugates Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Antibody Drug Conjugates Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Antibody Drug Conjugates Production (K Units) Growth Rate Forecast (2020-2025) Figure China Antibody Drug Conjugates Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: Multi Market Insight
Chat with us